TTS Pharma Ltd

Board of Directors

Paul Atherton

Chairman, Director

Paul was until 2018 the Chief Executive Officer of Heritage Oil Limited, which held both production and exploration assets around the world. The company was one of the largest oil and gas companies listed on the Main Board of the London Stock Exchange and a member of the FTSE 250, before being taken private for US$1.6 billion in 2014. During this time Paul executed significant fundraisings, mergers and acquisitions and the eventual privatisation, generating outstanding shareholder returns. Paul is a Chartered Accountant having qualified at Deloitte and worked in Corporate Finance at BDO. 

Wilson Blaney BSc (Hons)

Director of Quality

As Director of Quality, Wilson has responsibility for ensuring our ‘quality ethos’ is embedded within the business culture at all levels. Standards and specifications of the products and production processes are integrated into upstream / downstream agreements with suppliers and clients within relevant regulatory requirements. Wilson was previously Head of Operations at an Imperial plc subsidiary (Nerudia – Next Generation Products) after a number of ‘Quality’ roles within the pharmaceutical sector incl. Sanofi Aventis, GSK, Boots, Genzyme, Novartis and IPSEN and is therefore familiar with a wide range of licensed products, processes and regulatory environments.